跳至主要内容
临床试验/NCT07482046
NCT07482046已完成2 期

Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population

Taisho Pharmaceutical Indonesia1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2023年5月30日最近更新:
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
37
试验地点
1
主要终点
Change in Thermal Sensation

研究概览

简要总结

The goal of this clinical trial is to evaluate the effectiveness of topical menthol as a cooling method during exercise in a hot air environment in healthy adult recreational runners aged 18 to 45 years.

The main questions it aims to answer are:

What is the difference in thermal sensation between the topical menthol gel application and a placebo during exercise? How does the application of topical menthol affect body temperature, heart rate, and physical performance compared to a placebo? Researchers will compare a 4% Menthol gel to a placebo gel in a cross-over design to see if the menthol gel improves thermal sensation, regulates body temperature, and enhances physical performance and comfort.

Participants will:

  1. Undergo a screening process including a medical history review, physical examination, resting ECG, blood sugar test, and a Bleep fitness test.
  2. Participate in two separate running activities at an athletic field, separated by a wash-out period of 7 days + 1 day.Have the assigned gel (menthol or placebo) applied to their neck, front upper arms, and front upper legs while running (specifically between kilometers 2.5 and 2.8).
  3. Complete pre-run and post-run assessments measuring weight, skin and tympanic temperature, heart rate, vertical jump height, running duration, perceived exertion (RPE), thermal sensation, and comfort.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults, 18 - 45 years old
  • Have a personal best 10-kilometer run time of under one hour (which will be confirmed during the screening of prospective Subjects through history taking) in the last 6 months.
  • Doing running training at least 3 times/week for the past 1 year
  • Have a level of heart-lung endurance or VO2max that is at least included in the average criteria (known through examination: Bleep test)
  • Meets Subject screening criteria by answering "No" to all questions on the Physical Activity Readiness Questionnaire (PAR-Q) questionnaire.
  • Have normal resting ECG and normal GDS results on screening of prospective Subjects.
  • At the time of the study, the body temperature was within the normal range

排除标准

  • Pregnant and/or breastfeeding women
  • Have had a musculoskeletal injury in the last three months and still have symptoms or complaints
  • Are experiencing acute infectious disorders, such as gastrointestinal, respiratory infections
  • During treatment for chronic diseases (e.g. high blood pressure or hypertension, diabetes or diabetes mellitus, heart disease)
  • Have a history of hypersensitivity or allergy to menthol or skin-applied products (especially gel-based products)
  • Has a history of cold allergy
  • Have a positive COVID-19 test result at the time of screening.

研究组 & 干预措施

Placebo Group

Placebo Comparator

Placebo: light blue gel where the active ingredient Menthol is replaced by purified water.

干预措施: Placebo (Other)

Menthol Group

Experimental

Light blue gel with the trademark Counterpain COOL® (License Number: POM QD. 111 709 501) containing the active substance Menthol 4%.

干预措施: Light blue gel with the trademark Counterpain COOL® (License Number: POM QD. 111 709 501) containing the active substance Menthol 4%. (Drug)

结局指标

主要结局

Change in Thermal Sensation

时间窗: Baseline (pre-run), during run (~20 minutes), and immediately post-run (within 5 minutes after running completion).

Assessed using a 7-point thermal sensation scale. The scale ranges from -3 to +3, where -3 represents "cold", 0 represents "neutral", and +3 represents "hot". A higher score indicates a greater sensation of heat.

次要结局

  • Change in Rating of Perceived Exertion (RPE)(Immediately post-run (within 5 minutes after running completion).)
  • Change in Tympanic Temperature(Baseline (pre-run) and immediately post-run (within 5 minutes after running completion).)
  • Running Duration(Post-run (within 5 minutes after running completion).)
  • Change in Perceived Comfort(Baseline (pre-run) and immediately post-run (within 5 minutes after running completion).)
  • Change in Hydration Status(Baseline (pre-run) and immediately post-run (within 5 minutes after running completion).)
  • Change in Heart Rate(Baseline (pre-run) and immediately post-run (within 5 minutes after running completion).)

研究者

发起方
Taisho Pharmaceutical Indonesia
申办方类型
Industry
责任方
Principal Investigator
主要研究者

A. Andi Kurniawan

dr. Sp.KO., Subsp.ALK(K)

Taisho Pharmaceutical Indonesia

研究点 (1)

Loading locations...

相似试验